G

GemPharmatech Co Ltd
SSE:688046

Watchlist Manager
GemPharmatech Co Ltd
SSE:688046
Watchlist
Price: 13.35 CNY -2.55%
Market Cap: 5.5B CNY
Have any thoughts about
GemPharmatech Co Ltd?
Write Note

GemPharmatech Co Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

GemPharmatech Co Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
G
GemPharmatech Co Ltd
SSE:688046
Revenue
ÂĄ622.2m
CAGR 3-Years
33%
CAGR 5-Years
63%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Revenue
ÂĄ38.5B
CAGR 3-Years
22%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Revenue
ÂĄ11.8B
CAGR 3-Years
20%
CAGR 5-Years
28%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Revenue
ÂĄ17.1B
CAGR 3-Years
28%
CAGR 5-Years
41%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Revenue
ÂĄ6.8B
CAGR 3-Years
17%
CAGR 5-Years
20%
CAGR 10-Years
30%
W
WuXi XDC Cayman Inc
HKEX:2268
Revenue
ÂĄ2.1B
CAGR 3-Years
180%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

GemPharmatech Co Ltd
Glance View

Market Cap
5.5B CNY
Industry
Life Sciences Tools & Services

GemPharmatech Co., Ltd. engages in research and development, manufacture, and sale of experimental mouse models. The company is headquartered in Nanjing, Jiangsu and currently employs 1,342 full-time employees. The company went IPO on 2022-04-25. The firm uses gene-editing and other technologies to produce mouse models. The firm also involves in the business of customized model breeding, drug efficacy analysis, and model customization. The Company’s products are mainly used to satisfy the experimental demands in the fields of gene function cognition, disease mechanisms analysis, drug target discovery, and other fundamental researches.

Intrinsic Value
21.04 CNY
Undervaluation 37%
Intrinsic Value
Price
G

See Also

What is GemPharmatech Co Ltd's Revenue?
Revenue
622.2m CNY

Based on the financial report for Dec 31, 2023, GemPharmatech Co Ltd's Revenue amounts to 622.2m CNY.

What is GemPharmatech Co Ltd's Revenue growth rate?
Revenue CAGR 5Y
63%

Over the last year, the Revenue growth was 20%. The average annual Revenue growth rates for GemPharmatech Co Ltd have been 33% over the past three years , 63% over the past five years .

Back to Top